Max Chat
Company Analysis Shandong Xinhua Pharmaceutical Company Limited
1. Summary
Advantages
- Current debt level 0% is below 100% and has decreased over 5 years from 17.55%.
Disadvantages
- Price (13.75 Β₯) is higher than fair price (8.02 Β₯)
- Dividends (0.71%) are below the sector average (1.83%).
- The stock's return over the last year (-31.66%) is lower than the sector average (-29.42%).
- The company's current efficiency (ROE=10.96%) is lower than the sector average (ROE=11.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Shandong Xinhua Pharmaceutical Company Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -4.7% | 0% | 0.5% |
| 90 days | -11.1% | -7.2% | 14.9% |
| 1 year | -31.7% | -29.4% | 31.4% |
000756 vs Sector: Shandong Xinhua Pharmaceutical Company Limited has slightly underperformed the "Healthcare" sector by -2.24% over the past year.
000756 vs Market: Shandong Xinhua Pharmaceutical Company Limited has significantly underperformed the market by -63.02% over the past year.
Stable price: 000756 is not significantly more volatile than the rest of the market on "Shenzhen Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 000756 with weekly volatility of -0.6088% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (13.75 Β₯) is higher than the fair price (8.02 Β₯).
Price is higher than fair: The current price (13.75 Β₯) is 41.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (31.82) is lower than that of the sector as a whole (69.4).
P/E vs Market: The company's P/E (31.82) is lower than that of the market as a whole (63.57).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.28) is lower than that of the sector as a whole (3.96).
P/BV vs Market: The company's P/BV (3.28) is lower than that of the market as a whole (3.79).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.74) is lower than that of the sector as a whole (6.51).
P/S vs Market: The company's P/S indicator (1.74) is lower than that of the market as a whole (5.87).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (20.19) is higher than that of the sector as a whole (11.85).
EV/Ebitda vs Market: The company's EV/Ebitda (20.19) is lower than that of the market as a whole (25.54).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 7.97% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (7.97%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (10.96%) is lower than that of the sector as a whole (11.95%).
ROE vs Market: The company's ROE (10.96%) is higher than that of the market as a whole (9.38%).
5.5. ROA
ROA vs Sector: The company's ROA (4.12%) is lower than that of the sector as a whole (5.4%).
ROA vs Market: The company's ROA (4.12%) is higher than that of the market as a whole (3.95%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.71% is below the average for the sector '1.83%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.71% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 0.71% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (22.73%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
